WAMES AGM 2023 – signs of hope for the future!

WAMES AGM 2023: hope for the future

 

Our annual business meeting on 17th June 2023 celebrated the first signs of hope that services for people with ME/CFS in Wales might be on the horizon. Many times over the years we have wondered if years of raising awareness about ME and calling for appropriate services might ever produce a positive result for our ignored community.

Service development

The unfortunate rise in the post viral illness of long COVID and the long awaited revised NICE guideline means that there is now a more receptive climate in the NHS and an authoritative roadmap for the future.

WAMES has been busy sharing with Welsh Government and Health Boards the needs and experiences of people living with ME, as funding has been allocated and plans are being made to include ME/CFS in health services.

Information sharing

Advocating for services is why WAMES was set up in 2001, but we quickly realised that families affected by ME in Wales also needed information, not just about our illness, but also about general services and ways to influence those services and our society, so we set up a website and newsletter. Our information sharing these days focuses on our news blog, helpline, twitter and Facebook, and we have recently added an e-newsletter and Instagram page.

Our website has been looking increasingly tired and dated so we launched a fundraising campaign which has got off to a good start.

The team

All this has taken place with a dwindling volunteer team. Just imagine what we could do with more help!

  • Chair & Campaigns coordinator: Jan Russell
  • Acting secretary: Tony Thompson
  • Acting treasurer: Liz Chandler
  • Youth & Care Officer, Media Contact & Helpline Coordinator: Sylvia Penny
  • Volunteering Coordinator: Sharon Williams
  • Communications Team volunteers: Jacob; Mia; Michelle; Caitlin

WAMES is different to many ME charities. We don’t exist to support each other and we don’t work for members and provide them with lots of services. Instead, we all work together to improve the quality of life for ALL people affected by ME in Wales. We do this with a small number of people and a limited budget.

All our volunteers have health issues and other commitments but we can all make a valuable contribution when working as a Team and sharing the workload.

Join us at this particularly exciting time for ME in Wales!

We need:

Treasurer; Secretary; WordPress volunteer (to help run the new website); Fundraising volunteers; Remote Office manager; Admin volunteers; Communications volunteers.

Get in touchsharon@wames.org.uk   jan@wames.org.uk

Help us…. Make a difference for ME in Wales!

 

 

gets? | WAMES (Working for ME in Wales)

 

Posted in News | Comments Off on WAMES AGM 2023 – signs of hope for the future!

More than one condition at a time – ME/CFS and comorbidities

What links conditions comorbid with ME/CFS?

 

Comorbidity… describes the existence of more than one disease or condition within your body at the same time. Comorbidities are usually long-term, or chronic. They may or may not interact with each other.  WebMD

 

German researchers have been looking at the many conditions that are experienced by people in addition to ME/CFS to see if there is a common thread running through them. They concluded that the problem might be in the blood vessels. Vascular dysfunction appears to be a strong common denominator. The main comorbid conditions investigated were:

  • mast cell activation (MCA)
  • dysmenorrhea (severe menstrual cramps) and endometriosis
  • postural tachycardia (POTS) and orthostatic intolerance
  • small fiber neuropathy (SFN)
  • decreased cerebral blood flow
  • brain fog

 

 

ME/CFS and comorbidities: linked by vascular pathomechanisms and vasoactive mediators? by  Klaus J Wirth and Matthias Löhn in
Medicina 2023, 59(5), 978; [doi.org/10.3390/medicina59050978] 18 May 2023 (This article belongs to the Special Issue Advances in ME/CFS Research and Clinical Care)

Hypothesis abstract:

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is often associated with various other syndromes or conditions including mast cell activation (MCA), dysmenorrhea and endometriosis, postural tachycardia (POTS) and small fiber neuropathy (SFN). The causes of these syndromes and the reason for their frequent association are not yet fully understood.

We previously published a comprehensive hypothesis of the ME/CFS pathophysiology that explains the majority of symptoms, findings and chronicity of the disease. We wondered whether some of the identified key pathomechanisms in ME/CFS are also operative in MCA, endometriosis and dysmenorrhea, POTS, decreased cerebral blood flow and SFN, and possibly may provide clues on their causes and frequent co-occurrence.

Our analysis indeed provides strong arguments in favor of this assumption, and we conclude that the main pathomechanisms responsible for this association are excessive generation and spillover into the systemic circulation of inflammatory and vasoactive tissue mediators, dysfunctional β2AdR, and the mutual triggering of symptomatology and disease initiation.

Overall, vascular dysfunction appears to be a strong common denominator in these linkages.

Posted in News | Tagged , , , , , , , , , | Comments Off on More than one condition at a time – ME/CFS and comorbidities

Give donations ‘In lieu of gifts’

Give donations ‘In lieu of gifts’ 

 

Why not celebrate your next special occasion by asking your friends and family to lend support to people with ME/CFS?

By asking your friends and family to donate to us instead of giving gifts at a birthday, Christmas, anniversary or wedding, you can enjoy your special day knowing you are making a real difference to the lives of people with ME/CFS.

When adding the suggestion to your gift ‘wish list’ remind the donor to tell the treasurer which occasion they wish to celebrate when they send cheques or transfer money.

Account name:    Welsh Association of ME & CFS
Account Number:  76392081
Sort Code:       09-01-55

Treasurer: Cornerstones, Clinton Road Lane, Penarth, Vale of Glamorgan CF64 3JD

OR set up a fundraising page on a fundraising platform to allow people to donate by debit or credit card.

 “I found it really easy to set up a birthday fundraiser on Facebook.”  Sharon, WAMES Volunteer

Posted in News | Comments Off on Give donations ‘In lieu of gifts’

Decode ME – more participants needed – spread the word!

Decode ME – the world’s largest  DNA study of ME/CFS

 

Led by Dr Chris Ponting the study aims to uncover whether the disease is partly genetic and, if so, help pinpoint what causes it.

They need tens of thousands of people to take part from home by taking the questionnaire and providing a saliva sample to study their DNA. You can do both from home.

They need 25,000 DNA samples and even more people to take the questionnaire.

They are also looking for 5,000 DNA samples from people who developed ME/CFS after a Covid-19 infection.

Take part

Over 20,000 people have completed the questionnaire.

Over 10,000 have been asked to provide a DNA sample.

Many more are needed!

 

People who are not online can also take part:

  • Ask for a printed version of the information and questionnaire.
  • Ask for help to record your answers over the phone.

Contact info@DecodeME.org.uk or phone 0808 196 8664

More information

 

Posted in News | Comments Off on Decode ME – more participants needed – spread the word!

Research: Fighting Post-COVID and ME/CFS – development of curative therapies

Developing curative therapies for Post-COVID and ME/CFS

 

Prof Carmen Scheibenbogen and German colleagues believe there is a need to explore treatments for ME/CFS and long COVID even though research hasn’t yet uncovered the full cause/s of the conditions and reliable diagnostic tests.

They have produced a list of drugs they believe are worth evaluating but only on strict subgroups of patients, defined by the WHO for PCS and the Canadian criteria for ME/CFS, using a consistent process.

“Our concept of a multipronged clinical trial platform approach addresses the complexity and heterogeneity of PCS and ME/CFS, enabling to test numerous drugs in clinical trials in a harmonized manner accompanied by comprehensive mechanistic studies. Such an approach will pave the way for more rapid development of drugs for PCS and ME/CFS to find therapeutic solutions for specific subgroups and finally all patients.

Further, it will allow the development and identification of precise diagnostic, prognostic and companion biomarkers ultimately leading to targeted and individualized therapies combatting the different disease mechanisms. Finally, the identification of biomarkers predicting response to treatment provides strong evidence for causative pathomechanisms.”

 

Fighting Post-COVID and ME/CFS – development of curative therapies, by Carmen Scheibenbogen, Judith T Bellmann-Strobl, Cornelia Heindrich, Kirsten Wittke, Elisa Stein, Christiana Franke, Harald Prüss, Hannah Preßler, Marie-Luise Machule, Heinrich Audebert, Carsten Finke5, Hanna G Zimmerman,  Birgit Sawitzki, Christian Meisel, Markus Tölle, Anne Krüger, Anna C Aschenbrenner, Joachim L Schultz, Marc D. Beyer, Markus Ralser, Michael Mülleder, Leif E Sander, Frank Konietschke, Friedemann Paul, Silvia Stojanov, Lisa Bruckert, Dennis M Hedderich, Franziska Knolle, Gabriela Riemekasten, Maria J Vehreschild, Oliver A Cornely, Uta Behrends and Susen Burock, in Frontiers in Medicine, Sec. Infectious Diseases: Pathogenesis and Therapy: Vol 10, 15 Jun 2023 [doi.org/10.3389/fmed.2023.1194754]

Research abstract:

The sequela of COVID-19 include a broad spectrum of symptoms that fall under the umbrella term post-COVID-19 condition or syndrome (PCS). Immune dysregulation, autoimmunity, endothelial dysfunction, viral persistence, and viral reactivation have been identified as potential mechanisms. However, there is heterogeneity in expression of biomarkers, and it is unknown yet whether these distinguish different clinical subgroups of PCS.

There is an overlap of symptoms and pathomechanisms of PCS with postinfectious myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

No curative therapies are available for neither ME/CFS nor PCS. The mechanisms identified so far provide targets for therapeutic interventions. To accelerate the development of therapies, we propose evaluating drugs targeting different mechanisms in clinical trial networks using harmonized diagnostic and outcome criteria and subgrouping patients based on a thorough clinical profiling including a comprehensive diagnostic and biomarker phenotyping.

Posted in News | Comments Off on Research: Fighting Post-COVID and ME/CFS – development of curative therapies

ME/CFS service development in Wales: an update

ME/CFS in Wales

 

Since the new NICE guideline for the diagnosis and management of ME/CFS was published in October 2021 WAMES has been asking the 7 Health Boards in Wales if they plan to implement the guideline and how they plan to improve care.

Some Health Boards have responded more positively than others, though all claimed to be encouraging staff to use the new NICE guideline. The focus on COVID and lack of funding were often cited as reasons for lack of action in developing management services.

WAMES also approached the Welsh Government asking them to play a part in encouraging service development, and finally in March 2023 the Health Minister, Eluned Morgan, announced some funding to extend long COVID services to ‘people with myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS), fibromyalgia and other post-viral associated conditions’.

The money is welcome, though many would say ‘too little too late’! WAMES has been following what Health Boards are planning to do with that money.

Aneurin Bevan UHB

ABUHB have not announced any plans to develop services and have not responded to WAMES’ enquiries.

Betsi Cadwaladr UHB

BCUHB began talks with WAMES about developing services for ME/CFS long before money became available. Those plans are now being incorporated into plans for a chronic conditions service. There is still an interest amongst some staff members in meeting the needs of people with ME/CFS in line with NICE, including the new lead of the CFS/ME service in Llanfairfechan, and WAMES will continue to engage with the service commissioners to ensure ME/CFS doesn’t get overlooked again.

Cardiff and Vale UHB

Plans are well underway to develop a Long Term Conditions service in the Cardiff and Vale area.  A Co-production group of people interested in many long term conditions has been working on self-management tools such as the development of the Keeping me well website. This is a work in progress and its advice for people with ME/CFS still needs to be improved!

WAMES has been contributing information for the service design process, and planners have been investigating other ME/CFS services for insights and exploring the possibility of medical input to this rehabilitation service.

A soft launch is expected in 2023. As they aim to cater for many conditions with a limited budget and staff, we may find that it will take time to roll out all aspects of an ME friendly service. Hopefully the invitation to WAMES and people with ME to offer constructive criticism will continue.

Cwm Taf Morgannwg UHB

WAMES has met with service designers to explain the needs of people with ME/CFS and promote the NICE guideline. Plans for the Long Term Conditions service are underway and will aim to include services for ME/CFS in line with NICE, although it is uncertain whether medical professionals will be involved. [A GP’s involvement has now been confirmed 14/6/23]

Hywel Dda UHB

Plans to extend the Long COVID service to other conditions are in the early stages but 2 staff members are actively investigating the best way to integrate ME/CFS services into that. They are also talking with WAMES and taking into account the results of engagement with patients in 2014-8.

Powys THB

WAMES has received no information about any plans for an ME-friendly service in Powys and has received no request to engage with patients and carers.

Swansea Bay UHB

SBUB had offered some support previously to some people with ME/CFS through their Rheumatology Occupational Therapy service. They have not revealed any plans to develop further services and have so far not responded to WAMES’ enquiries about it.

You can help!

WAMES will continue to engage with the Health Boards as much as we can. The more information we have about the way the NHS is treating people with ME, the better we can advocate for you.

  • Tell us about your recent NHS experiences
  • Ask your GP what is recorded about you in your NHS record. Particularly how your illness is coded (Read, SNOMED etc.)
  • Ask for a confirmation of an ME/CFS diagnosis if you do not have one. Are they familiar with the NICE guideline?
  • Take part in the MEA’s #CountMEin survey of NHS experiences.
Posted in News | Comments Off on ME/CFS service development in Wales: an update

Research: Alcohol intolerance & ME/CFS

Alcohol intolerance and myalgic encephalomyelitis/chronic fatigue syndrome

 

Using questionnaires and statistical analysis Jason & Machiuch found that people with ME/CFS are more likely to experience alcohol intolerance. Those with alcohol intolerance had more symptoms, including orthostatic intolerance.

Alcohol intolerance and myalgic encephalomyelitis/chronic fatigue syndrome, by Jessica Maciuch, Leonard A Jason in World J Neurol. May 31, 2023; 9(3): 17-27  [doi: 10.5316/wjn.v9.i3.17]

Research abstract: 

BACKGROUND

The literature is mixed about the occurrence of alcohol intolerance among patients with myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS). Surveys that asked respondents with ME/CFS whether they experienced alcohol intolerance within a recent time frame might produce inaccurate results because respondents may indicate that the symptom was not present if they avoid alcohol due to alcohol intolerance.

AIM

To overcome this methodologic problem, participants in the current study were asked whether they have avoided alcohol in the past 6 mo, and if they had, how severe their alcohol intolerance would be if they were to drink alcohol.

METHODS

The instrument used was a validated scale called the DePaul symptom questionnaire. Independent t-tests were performed among the alcohol intolerant or not alcohol intolerant group. The alcohol intolerant group had 208 participants, and the not alcohol intolerant group had 96 participants.

RESULTS

Using specially designed questions to properly identify those with alcohol intolerance, those who experienced alcohol intolerance vs those who did not experience alcohol intolerance experienced more frequent/severe symptoms and domains.

In addition, using a multiple regression analysis, the orthostatic intolerance symptom domain was related to alcohol intolerance.

CONCLUSION

The findings from the current study indicated that those with ME/CFS are more likely to experience alcohol intolerance. In addition, those with this symptom have more overall symptoms than those without alcohol intolerance. 

Posted in News | Tagged , , | Comments Off on Research: Alcohol intolerance & ME/CFS

Videos: INIM ME/CFS conference 2023

Institute for Neuro-Immune Medicine Conference 2023

 

On May 19th in Florida USA the INIM conference, led by Dr Nancy Klimas explored the many parallels formed around COVID-19 and ME/CFS.

Viral Reactivation, Mast Cell Activation, Systemic and Vascular Inflammation, and many more similarities have been seen.

View the video and read the transcript[3h 40]:

Contents

  • COVID’s urgency forced the world to look at neuro-inflammation & mast cells: (Dr Klimas MD & Dr Theoharides, MS, Mphil, Phd, MD)
  • Environmental medicine – reducing home toxins (Dr Rey, MD)
  • EBV reactivation in post viral illness & neuro toxic injury (Travis Craddock, Phd)
  • Nutrients that impact the immune system (Haylie Pomroy, MS)
  • Insomnia – holistic solutions and support (Dr Junco, MD, MPH, AP)
  • Question and answer session

Health Rising: A moonshot for ME/CFS, knocking EBV down and a stuck Long-COVID Study: the 2023 INIM conference highlights

Posted in News | Tagged , , , , , , , , , , , , , , | Comments Off on Videos: INIM ME/CFS conference 2023

Video lecture: Using wearable technology with Long COVID & ME/CFS

Wearable technology for long COVID and ME/CFS with Harry Leeming

 

This video lecture by Harry Leeming is one of the Massachusetts ME/CFS & FM Association‘s May Sunday Conversations series.

A former engineer, Harry Leeming has worked at multiple early-stage start-ups in Silicon Valley as well as in Formula 1.

Harry founded the company Visible, an activity tracking platform for Long COVID and ME/CFS, as a result of his own health condition, and aims to use the platform to help increase our understanding of complex chronic illness.

In this edition of Sunday Conversations with MassME, Harry gave a brief overview of the application, with descriptions of the team, their HRV-centered philosophy, and their plans for the rollout of their own wearable device specifically for pacing and symptom tracking.

He then took questions from the Zoom audience about the timeline of future releases and features, cost and geographic availability of the premium service, the potential for use in research, various user interface ideas and suggestions, and much more.

Posted in News | Tagged , , , , , , | Comments Off on Video lecture: Using wearable technology with Long COVID & ME/CFS

Research review: ME/CFS & Long COVID share similar symptoms & biological abnormalities

ME/CFS and Long COVID share similar symptoms and biological abnormalities

 

“In this review, we first compare the symptoms of ME/CFS and Long COVID, noting the considerable similarities and the few differences. We then compare in extensive detail the underlying pathophysiology of these two conditions, focusing on abnormalities of the central and autonomic nervous system, lungs, heart, vasculature, immune system, gut microbiome, energy metabolism and redox balance.”

ME/CFS and Long COVID share similar symptoms

 

ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature, by Anthony L Komaroff and W Ian Lipkin in Front. Med., 02 June 2023; Sec. Infectious Diseases: Pathogenesis and Therapy, Vol 10 – 2023 [doi.org/10.3389/fmed.2023.1187163]

Some patients remain unwell for months after “recovering” from acute COVID-19. They develop persistent fatigue, cognitive problems, headaches, disrupted sleep, myalgias and arthralgias, post-exertional malaise, orthostatic intolerance and other symptoms that greatly interfere with their ability to function and that can leave some people housebound and disabled.

The illness (Long COVID) is similar to myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) as well as to persisting illnesses that can follow a wide variety of other infectious agents and following major traumatic injury.  Together, these illnesses are projected to cost the U.S. trillions of dollars.

In this review, we first compare the symptoms of ME/CFS and Long COVID, noting the considerable similarities and the few differences. We then compare in extensive detail the underlying pathophysiology of these two conditions, focusing on abnormalities of the central and autonomic nervous system, lungs, heart, vasculature, immune system, gut microbiome, energy metabolism and redox balance. This comparison highlights how strong the evidence is for each abnormality, in each illness, and helps to set priorities for future investigation.

The review provides a current road map to the extensive literature on the underlying biology of both illnesses.

Conclusion

We urge that investigators studying the underlying biology of Long COVID take note of the robust findings in ME/CFS that have not yet been investigated in Long COVID: given the many similarities in the underlying biology of the two illnesses, it is likely that pursuing such abnormalities in Long COVID will prove instructive.

Research into the pathophysiology of these responses has the potential to lead to new strategies for reducing the morbidity of ME/CFS and Long COVID, and of similar illnesses that can follow a variety of infections and non-infectious traumatic injury.

Posted in News | Tagged , , | Comments Off on Research review: ME/CFS & Long COVID share similar symptoms & biological abnormalities